These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1535112)

  • 1. [The clinical picture and outcome of acute delta infection].
    Negresku GV; Iashina TL; Burkov AN; Favorov MO
    Klin Med (Mosk); 1992 Jan; 70(1):80-4. PubMed ID: 1535112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Delta hepatitis as a mixed infection].
    Fedorchenko SV; Vovk AD; Vozianova SV
    Vrach Delo; 1990 Mar; (3):5-8. PubMed ID: 2195767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IgM anti-HBc in the differential diagnosis of co- and HDV superinfection].
    Fedorchenko SV; Vozianova SV
    Ter Arkh; 1991; 63(11):55-8. PubMed ID: 1810065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
    Aragona M; Macagno S; Caredda F; Crivelli O; Lavarini C; Bertolusso L; Farci P; Rizzetto M
    Prog Clin Biol Res; 1987; 234():243-8. PubMed ID: 3628379
    [No Abstract]   [Full Text] [Related]  

  • 6. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta viral replication markers in acute and chronic D infection.
    Buti M
    Prog Clin Biol Res; 1991; 364():201-5. PubMed ID: 2020696
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
    el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
    Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
    Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
    Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses].
    Muñoz Espinosa LE; Ibarra Salas MJ
    Rev Gastroenterol Mex; 1997; 62(4):246-9. PubMed ID: 9580232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short communication: evaluation of the correlation between hepatitis D virus (HDV) RNA positivity and HDV antibodies].
    Ozekinci T; Atmaca S; Akpolat N; Temiz H; Arikan E
    Mikrobiyol Bul; 2005 Jul; 39(3):345-9. PubMed ID: 16358495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
    Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
    Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
    Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
    Lake-Bakaar G; Bhat K; Govindarajan S
    J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hepatitis D virus infection: changes in the last 14 years.
    Navascués CA; Rodríguez M; Sotorrío NG; Sala P; Linares A; Suárez A; Rodrigo L
    Am J Gastroenterol; 1995 Nov; 90(11):1981-4. PubMed ID: 7485005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(3):35-6. PubMed ID: 7890271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis B and delta: the prevalence of seroepidemiological markers in volunteer blood donors and their families].
    Alvarez-Muñoz MT; Bustamante-Calvillo ME; Guiscafré-Gallardo JP; Muñoz O
    Gac Med Mex; 1991; 127(5):399-404. PubMed ID: 1790848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta infection in patients and HBsAg carriers.
    Ketiladze ES; Vyazov SO; Chernovetsky MA; Mikhailov MI; Bugayeva NP; Kozlova TP
    Prog Clin Biol Res; 1987; 234():461-6. PubMed ID: 3628413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.